Nature Neuroscience, Published online: 08 September 2026; doi:10.1038/s41593-026-02417-7Alzheimer’s disease progression involves reduced bone marrow production of myeloid cells due to type I interferon signaling, which hampers the homing of protective immune cells to the affected brain. In a mouse model, inhibiting this pathway restored immune cell recruitment and halted disease progression.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: | September 8, 2026
NeuroScience